ALK, ROS1, and RET - Does the Partner Gene Matter?

被引：0
|
作者：
Lovly, Christine [1 ]
Childress, Merrida [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
RET; ros1; NTRK1; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS22.02
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [31] Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma
    Tang, Zhenya
    Zhang, Jianjun
    Lu, Xinyan
    Wang, Wei
    Chen, Hui
    Robinson, Melissa K.
    Cheng, Joanne
    Tang, Guilin
    Medeiros, L. Jeffrey
    MODERN PATHOLOGY, 2018, 31 (02) : 307 - 312
  • [32] THE PREVALENCE AND CLINICOPATHOLOGIC FEATURE OF ALK, ROS1 AND RET FUSIONS IN EAST ASIAN PATIENTS WITH LUNG ADENOCARCINOMA
    Cai, Weijing
    Zhou, Caicun
    Ren, Shengxiang
    Su, Chunxia
    Li, Xuefei
    Li, Wei
    Li, Shuai
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S660 - S660
  • [33] ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers
    Mulkidjan, Rimma S.
    Saitova, Evgeniya S.
    Preobrazhenskaya, Elena V.
    Asadulaeva, Karimat A.
    Bubnov, Mikhail G.
    Otradnova, Ekaterina A.
    Terina, Darya M.
    Shulga, Sofia S.
    Martynenko, Darya E.
    Semina, Maria V.
    Belogubova, Evgeniya V.
    Tiurin, Vladislav I.
    Amankwah, Priscilla S.
    Martianov, Aleksandr S.
    Imyanitov, Evgeny N.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [34] A next generation sequencing assay to detect the fusion products of ALK, ROS1 and RET with any fusion partner genes and hotspot mutations in FFPE samples
    Xu, Qiang
    Wang, Guan
    Li, Bo
    Qian, Maoxiang
    Fang, Douglas
    Sun, Lele
    Chen, Yundi
    Sun, Hongye
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC
    Li, Weihua
    Guo, Lei
    Liu, Yutao
    Dong, Lin
    Yang, Lin
    Chen, Li
    Liu, Kaihua
    Shao, Yang
    Ying, Jianming
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : 404 - 418
  • [36] Mechanisms of acquired resistance to ALK/ROS1 inhibitors
    Shaw, Alice T.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [37] ALK and ROS1 Expression in Inflammatory Myofibroblastic Tumor
    Yamamoto, Hidetaka
    Taguchi, Kenichi
    Yoshida, Akihiko
    Kohashi, Kenichi
    Oda, Yoshinao
    MODERN PATHOLOGY, 2015, 28 : 29A - 29A
  • [38] ALK and ROS1 Expression in Inflammatory Myofibroblastic Tumor
    Yamamoto, Hidetaka
    Taguchi, Kenichi
    Yoshida, Akihiko
    Kohashi, Kenichi
    Oda, Yoshinao
    LABORATORY INVESTIGATION, 2015, 95 : 29A - 29A
  • [39] Overview of ALK and ROS1 Rearranged Lung Cancer
    Choi, Chang Min
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (06) : 236 - 237
  • [40] ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
    Yamamoto, Hidetaka
    Yoshida, Akihiko
    Taguchi, Kenichi
    Kohashi, Kenichi
    Hatanaka, Yui
    Yamashita, Atsushi
    Mori, Daisuke
    Oda, Yoshinao
    HISTOPATHOLOGY, 2016, 69 (01) : 72 - 83
12345